Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Retained Earnings (2020 - 2025)

Rapid Micro Biosystems (RPID) has disclosed Retained Earnings for 6 consecutive years, with -$522.4 million as the latest value for Q4 2025.

  • Quarterly Retained Earnings fell 9.91% to -$522.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$522.4 million through Dec 2025, down 9.91% year-over-year, with the annual reading at -$522.4 million for FY2025, 9.91% down from the prior year.
  • Retained Earnings hit -$522.4 million in Q4 2025 for Rapid Micro Biosystems, down from -$509.9 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $83000.0 in Q3 2024 to a low of -$522.4 million in Q4 2025.
  • Historically, Retained Earnings has averaged -$222.1 million across 5 years, with a median of -$275.5 million in 2021.
  • Biggest five-year swings in Retained Earnings: surged 118.32% in 2024 and later plummeted 1993480.0% in 2025.
  • Year by year, Retained Earnings stood at -$16000.0 in 2021, then tumbled by 6831.25% to -$1.1 million in 2022, then crashed by 38528.04% to -$428.4 million in 2023, then fell by 10.95% to -$475.3 million in 2024, then decreased by 9.91% to -$522.4 million in 2025.
  • Business Quant data shows Retained Earnings for RPID at -$522.4 million in Q4 2025, -$509.9 million in Q3 2025, and -$498.4 million in Q2 2025.